This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Opexa Therapeutics Inc
OPXA : NASDAQ : Health Care
$1.47 0.01 | 0.68%
Today's Range: 1.44 - 1.48
Avg. Daily Volume: 165,400
08/22/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
OPXA OPEXA THERAPEUTICS INC 1.53 42.32 n/m 1.40 534.54
KBIO KALOBIOS PHARMACEUTICALS INC 1.60 52.78 n/m 0.03 -72.82
ENZN ENZON PHARMACEUTICALS INC 1.17 51.63 2.21 33.29 -21.10
MNOV MEDICINOVA INC 2.00 48.29 n/m 6.00 875.60
LPDX LIPOSCIENCE INC 3.03 46.29 n/m 46.51 -13.95
RXII RXI PHARMACEUTICALS CORP 2.77 44.61 n/m 0.38 150.00
GNVC GENVEC INC 2.11 36.44 n/m 4.61 -37.73
XTLB XTL BIOPHARMACEUTICALS 2.40 28.34 n/m 2.28 41.71
IBIO IBIO INC 0.42 27.57 n/m 0.66 -13.45
DARA DARA BIOSCIENCES INC 1.37 26.72 n/m 0.56 645.33
CBLI CLEVELAND BIOLABS INC 0.42 23.99 n/m 7.40 38.10
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

OPXA Ind Avg S&P 500
n/m 79.45 19.39

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs